These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 12857894

  • 1. Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein.
    Isaacs SN, Argyropoulos E, Sfyroera G, Mohammad S, Lambris JD.
    J Virol; 2003 Aug; 77(15):8256-62. PubMed ID: 12857894
    [Abstract] [Full Text] [Related]

  • 2. Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b.
    Bernet J, Mullick J, Panse Y, Parab PB, Sahu A.
    J Virol; 2004 Sep; 78(17):9446-57. PubMed ID: 15308738
    [Abstract] [Full Text] [Related]

  • 3. Glycosylated and nonglycosylated complement control protein of the lister strain of vaccinia virus.
    Meseda CA, Kuhn J, Atukorale V, Campbell J, Weir JP.
    Clin Vaccine Immunol; 2014 Sep; 21(9):1330-8. PubMed ID: 25030055
    [Abstract] [Full Text] [Related]

  • 4. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation.
    Liszewski MK, Leung MK, Hauhart R, Buller RM, Bertram P, Wang X, Rosengard AM, Kotwal GJ, Atkinson JP.
    J Immunol; 2006 Mar 15; 176(6):3725-34. PubMed ID: 16517741
    [Abstract] [Full Text] [Related]

  • 5. Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.
    Kaever T, Matho MH, Meng X, Crickard L, Schlossman A, Xiang Y, Crotty S, Peters B, Zajonc DM.
    J Virol; 2016 May 15; 90(9):4334-4345. PubMed ID: 26889021
    [Abstract] [Full Text] [Related]

  • 6. Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP).
    Rosengard AM, Alonso LC, Korb LC, Baldwin WM, Sanfilippo F, Turka LA, Ahearn JM.
    Mol Immunol; 1999 Jul 15; 36(10):685-97. PubMed ID: 10509819
    [Abstract] [Full Text] [Related]

  • 7. Identification of complement regulatory domains in vaccinia virus complement control protein.
    Mullick J, Bernet J, Panse Y, Hallihosur S, Singh AK, Sahu A.
    J Virol; 2005 Oct 15; 79(19):12382-93. PubMed ID: 16160165
    [Abstract] [Full Text] [Related]

  • 8. Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.
    Kumar J, Yadav VN, Phulera S, Kamble A, Gautam AK, Panwar HS, Sahu A.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28724763
    [Abstract] [Full Text] [Related]

  • 9. Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity.
    Bernet J, Ahmad M, Mullick J, Panse Y, Singh AK, Parab PB, Sahu A.
    Vaccine; 2011 Oct 06; 29(43):7435-43. PubMed ID: 21803094
    [Abstract] [Full Text] [Related]

  • 10. Potent neutralization of vaccinia virus by divergent murine antibodies targeting a common site of vulnerability in L1 protein.
    Kaever T, Meng X, Matho MH, Schlossman A, Li S, Sela-Culang I, Ofran Y, Buller M, Crump RW, Parker S, Frazier A, Crotty S, Zajonc DM, Peters B, Xiang Y.
    J Virol; 2014 Oct 06; 88(19):11339-55. PubMed ID: 25031354
    [Abstract] [Full Text] [Related]

  • 11. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A, Isaacs SN, Soulika AM, Lambris JD.
    J Immunol; 1998 Jun 01; 160(11):5596-604. PubMed ID: 9605165
    [Abstract] [Full Text] [Related]

  • 12. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence.
    Isaacs SN, Kotwal GJ, Moss B.
    Proc Natl Acad Sci U S A; 1992 Jan 15; 89(2):628-32. PubMed ID: 1731333
    [Abstract] [Full Text] [Related]

  • 13. Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement.
    Benhnia MR, McCausland MM, Moyron J, Laudenslager J, Granger S, Rickert S, Koriazova L, Kubo R, Kato S, Crotty S.
    J Virol; 2009 Feb 15; 83(3):1201-15. PubMed ID: 19019965
    [Abstract] [Full Text] [Related]

  • 14. Regulation of complement activity by vaccinia virus complement-control protein.
    McKenzie R, Kotwal GJ, Moss B, Hammer CH, Frank MM.
    J Infect Dis; 1992 Dec 15; 166(6):1245-50. PubMed ID: 1431243
    [Abstract] [Full Text] [Related]

  • 15. Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein.
    Ahmad M, Raut S, Pyaram K, Kamble A, Mullick J, Sahu A.
    J Immunol; 2010 Nov 15; 185(10):6128-37. PubMed ID: 20956343
    [Abstract] [Full Text] [Related]

  • 16. Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5.
    Benhnia MR, McCausland MM, Laudenslager J, Granger SW, Rickert S, Koriazova L, Tahara T, Kubo RT, Kato S, Crotty S.
    J Virol; 2009 Dec 15; 83(23):12355-67. PubMed ID: 19793826
    [Abstract] [Full Text] [Related]

  • 17. Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.
    Yadav VN, Pyaram K, Mullick J, Sahu A.
    J Virol; 2008 Apr 15; 82(7):3283-94. PubMed ID: 18216095
    [Abstract] [Full Text] [Related]

  • 18. Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies.
    Czerny CP, Mahnel H.
    J Gen Virol; 1990 Oct 15; 71 ( Pt 10)():2341-52. PubMed ID: 1700065
    [Abstract] [Full Text] [Related]

  • 19. Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.
    Mark L, Proctor DG, Blackbourn DJ, Blom AM, Spiller OB.
    Immunology; 2008 Feb 15; 123(2):228-38. PubMed ID: 17764451
    [Abstract] [Full Text] [Related]

  • 20. Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance.
    Smith SA, Sreenivasan R, Krishnasamy G, Judge KW, Murthy KH, Arjunwadkar SJ, Pugh DR, Kotwal GJ.
    Biochim Biophys Acta; 2003 Aug 21; 1650(1-2):30-9. PubMed ID: 12922167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.